Literature DB >> 6095448

Characterization and molecular cloning of a human parvovirus genome.

S F Cotmore, P Tattersall.   

Abstract

The genome of the small human virus serologically associated with erythrocyte aplasia and erythema infectiosum (fifth disease) is shown to be a linear, nonpermuted, single-stranded DNA molecule with self-priming hairpin termini, properties which are characteristic of the genomes of the family Parvoviridae. This human parvovirus chromosome was molecularly cloned into bacterial plasmid vectors and the cloned DNA was used to explore its relatedness to other mammalian parvovirus serotypes by DNA:DNA hybridization. It is not related to the human adeno-associated viruses but does show a distant evolutionary relationship to genomes of the helper-independent parvoviruses of rodents. This strongly suggests that it is an autonomous parvovirus, and as such is the first example of a member of this group of common animal pathogens to cause disease in man.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095448     DOI: 10.1126/science.6095448

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  51 in total

Review 1.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

2.  Influence of extraction protocol on physical properties of parvovirus B19 DNA.

Authors:  Bertfried Matz; Bernd Kupfer; Thomas R Kreil; Anna Maria Eis-Hübinger
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

3.  Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity.

Authors:  Ning Zhi; Ian P Mills; Jun Lu; Susan Wong; Claudia Filippone; Kevin E Brown
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies.

Authors:  H Sato; J Hirata; N Kuroda; H Shiraki; Y Maeda; K Okochi
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

5.  A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response.

Authors:  K Yoshimoto; S Rosenfeld; N Frickhofen; D Kennedy; R Hills; S Kajigaya; N S Young
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome.

Authors:  Wuxiang Guan; Fang Cheng; Yuko Yoto; Steve Kleiboeker; Susan Wong; Ning Zhi; David J Pintel; Jianming Qiu
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

7.  Comparison of 17 isolates of the human parvovirus B 19 by restriction enzyme analysis. Brief report.

Authors:  F Morinet; J D Tratschin; Y Perol; G Siegl
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

8.  Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus.

Authors:  C H Srivastava; R J Samulski; L Lu; S H Larsen; A Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity.

Authors:  M Momoeda; S Wong; M Kawase; N S Young; S Kajigaya
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.

Authors:  Yong Luo; Steve Kleiboeker; Xuefeng Deng; Jianming Qiu
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.